American Research & Management Co. Cuts Stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)


Share on StockTwits

American Research & Management Co. reduced its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 6.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,185 shares of the financial services provider’s stock after selling 145 shares during the period. American Research & Management Co.’s holdings in iShares Nasdaq Biotechnology ETF were worth $329,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. First Trust Advisors LP increased its position in iShares Nasdaq Biotechnology ETF by 69.0% during the 1st quarter. First Trust Advisors LP now owns 16,417 shares of the financial services provider’s stock worth $1,835,000 after purchasing an additional 6,701 shares in the last quarter. Eudaimonia Partners LLC increased its position in iShares Nasdaq Biotechnology ETF by 2,566.8% during the 3rd quarter. Eudaimonia Partners LLC now owns 27,255 shares of the financial services provider’s stock worth $494,000 after purchasing an additional 26,233 shares in the last quarter. Intrua Financial LLC acquired a new stake in iShares Nasdaq Biotechnology ETF during the 3rd quarter worth approximately $206,000. Stumpf Capital Management LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the third quarter valued at approximately $34,000. Finally, Alhambra Investment Partners LLC acquired a new stake in iShares Nasdaq Biotechnology ETF in the third quarter valued at approximately $379,000. Institutional investors and hedge funds own 79.80% of the company’s stock.

NASDAQ:IBB traded up $1.16 during trading hours on Thursday, hitting $150.01. The stock had a trading volume of 51,272 shares, compared to its average volume of 3,333,646. iShares Nasdaq Biotechnology ETF has a 1-year low of $109.36 and a 1-year high of $174.04. The business has a 50 day simple moving average of $154.90 and a two-hundred day simple moving average of $152.85.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Dividend Achievers

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.